Hansoh Pharma reported 33% YoY net profit growth on 21% YoY revenue growth in 2024. Revenue from innovative drugs grew 38% YoY and its proportion to revenue increased to 77% in 2024 from 68% in 2023.
What is covered in the Full Insight:
Introduction
Financial Performance 2024
Product Pipeline and R&D Strategy
Outlicensing and Collaboration
Conclusion and Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.